• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)

    2/23/23 5:01:46 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ADOC alert in real time by email
    SC 13G/A 1 tm237712d2_sc13ga.htm SC 13G/A

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934
    (Amendment No. 1)*

     

    EDOC Acquisition Corp.

    (Name of Issuer)

     

    Class A Ordinary Shares, $0.0001 par value

    (Title of Class of Securities)

     

    G4000A102

    (CUSIP Number)

     

    NICHOLAS SABATINI, CFO & CCO; 1555 POST ROAD EAST, SUITE 202, WESTPORT, CT 06880; (203) 341-0702

    (Name, Address and Telephone Number of Person
    Authorized to Receive Notices and Communications)

     

    February 15, 2023

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:


    x Rule 13d-1(b)
    ¨ Rule 13d-1(c)
    ¨ Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

    1. NAMES OF REPORTING PERSONS

    Yakira Partners, L.P.
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a) ¨
    (b) ¨
    3.

    SEC USE ONLY

     

    4. CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5. SOLE VOTING POWER

    24,378
    6.

    SHARED VOTING POWER

     

    7. SOLE DISPOSITIVE POWER

    24,378
    8. SHARED DISPOSITIVE POWER

    0
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    24,378
    10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions) ¨
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    1.73%
    12. TYPE OF REPORTING PERSON (see instructions)

    PN
           

     

     

     

    1. NAMES OF REPORTING PERSONS

    Yakira Enhanced Offshore Fund Ltd. 
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a) ¨
    (b) ¨
    3.

    SEC USE ONLY

     

    4. CITIZENSHIP OR PLACE OF ORGANIZATION

    Cayman Islands
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5. SOLE VOTING POWER

    2,000
    6.

    SHARED VOTING POWER

     

    0

    7. SOLE DISPOSITIVE POWER

    2,000
    8. SHARED DISPOSITIVE POWER

    0
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    2,000
    10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions) ☐
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    0.14%
    12. TYPE OF REPORTING PERSON (see instructions)

    FI
           

     

     

     

    1. NAMES OF REPORTING PERSONS

    MAP 136 Segregated Portfolio
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (see instructions)
    (a) ¨
    (b) ¨
    3.

    SEC USE ONLY

     

    4. CITIZENSHIP OR PLACE OF ORGANIZATION

    Cayman Islands
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5. SOLE VOTING POWER

    0
    6. SHARED VOTING POWER

    0
    7. SOLE DISPOSITIVE POWER

    0
    8. SHARED DISPOSITIVE POWER

    0
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    0
    10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    (see instructions) ¨
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    0.00%
    12. TYPE OF REPORTING PERSON (see instructions)

    FI
           

     

     

     

    Item 1.

     

      (a) Name of Issuer

      

    EDOC Acquisition Corp.

      

      (b) Address of Issuer’s Principal Executive Offices

     

    7612 Main Street Fishers, Suite 200, Victor, NY 14564 

     

    Item 2.

     

      (a) Name of Person Filing

     

    This Statement is filed by Yakira Capital Management, Inc. on behalf of each of the following persons (collectively, the “Reporting Persons”)

     

      i) Yakira Partners, L.P.

     

      ii) Yakira Enhanced Offshore Fund Ltd.

     

      iii) MAP 136 Segregated Portfolio

     

      (b) Address of the Principal Office or, if none, residence

     

    1555 Post Road East, Suite 202, Westport, CT 06880

     

      (c) Citizenship

     

    Yakira Capital Management, Inc. and Yakira Partners L.P. are Delaware entities.

    Yakira Enhanced Offshore Fund Ltd. and MAP 136 Segregated Portfolio are Cayman Island entities.

     

      (d) Title of Class of Securities

     

    Class A Ordinary Shares, $0.0001 par value

     

      (e) CUSIP Number

     

    G4000A102

     

     

     

     

    Item 3. Filing pursuant to §240.13d-1(b)

     

    If this statement is filed pursuant to Sec. 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a :

     

      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.D. 78o):

     

      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

     

      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

     

      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);

     

      (e) x An investment adviser in accordance with Sec. 240.13d-1(b)(1)(ii)(E);

     

      (f) ¨ An employee benefit plan or endowment fund in accordance with Sec. 240.13d-1(b)(1)(ii)(F);

     

      (g) ¨ A parent holding company or control person in accordance with Sec. 240.13d-1(b)(1)(ii)(G);

     

      (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

      (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

     

      (j) ¨ A non-U.S. institution in accordance with Sec. 240.13d-1(b)(1)(ii)(J);

     

      (k) ¨ Group, in accordance with Sec. 240.13d-1(b)(1)(ii)(J).

     

    Item 4. Ownership

     

      (a) Amount Beneficially Owned: 26,378 shares

     

      (b) Percent of Class: 1.87%

     

      (c) Number of shares to which the person has:

     

      (i) Sole power to vote or to direct the vote: 26,378

     

      (ii) Shared power to vote or to direct the vote: 0

     

      (iii) Sole power to dispose or to direct the disposition: 26,378

     

      (iv) Shared power to dispose or to direct the disposition: 0

     

     

     

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following x.

     

    Item 6. Ownership of More than Five Percent on Behalf of another Person.

     

    Not Applicable

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

     

    Not Applicable

     

    Item 8. Identification and Classification of Members of the Group.

     

    Not Applicable

     

    Item 9. Notice of Dissolution of Group.

     

    Not Applicable

     

     

     

     

    Item 10. Certification

      

    By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

        2/23/2023
        Date
         
    YAKIRA CAPITAL MANAGEMENT, INC.

     

     

     

     

     

    /s/ Nicholas Sabatini

       
    Authorized Signatory    
         

     

     

    Get the next $ADOC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADOC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ADOC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Edoc Acquisition Corp. Announces Postponement of Special Meeting of Shareholders on Proposed Business Combination

    Victor, NY, Feb. 27, 2024 (GLOBE NEWSWIRE) -- EDOC Acquisition Corp. (NASDAQ:ADOC) ("EDOC") announced today that it has postponed its extraordinary general meeting of its shareholders (the "Meeting") to approve its proposed initial business combination, which was re-scheduled from February 26, 2024 to February 28, 2024, has been further postponed to 4:30p.m. Eastern Time, on Tuesday, March 5, 2024. At the Meeting, shareholders of EDOC will be asked to vote on proposals to approve, among other things, its proposed initial business combination with Australian Oilseeds Holdings Limited, a Cayman Islands exempted company ("Pubco"), pursuant to a Business Combination Agreement by and among EDOC

    2/27/24 5:32:10 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Edoc Acquisition Corp. Announces Postponement of Special Meeting of Stockholders on Proposed Business Combination

    Victor, NY, Feb. 23, 2024 (GLOBE NEWSWIRE) --  EDOC Acquisition Corp. (NASDAQ:ADOC) ("EDOC") announced today that it has postponed its extraordinary general meeting of its shareholders (the "Meeting") to approve its proposed initial business combination, which was scheduled for February 26, 2024, has been postponed to 10:00 a.m. Eastern Time, on Wednesday, February 28, 2024. At the Meeting, shareholders of EDOC will be asked to vote on proposals to approve, among other things, its proposed initial business combination with Australian Oilseeds Holdings Limited, a Cayman Islands exempted company ("Pubco"), pursuant to a Business Combination Agreement by and among EDOC, American Physicians LL

    2/23/24 5:45:00 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Australian Oilseeds and EDOC Acquisition Corp. Announce Effectiveness of Registration Statement and Date of Shareholder Meeting to Approve Proposed Business Combination

    ~ Shareholder Meeting of EDOC Acquisition Corp. to Approve Business CombinationScheduled for February 26, 2024 ~ ~ EDOC Shareholders of Record as of February 2, 2024, are Eligible to Vote at Meeting ~ ~ Upon Closing, Australian Oilseeds Investments Pty Ltd. is Expected to Trade on Nasdaq Under the Ticker "COOT" ~ Victor, NY and Cootamundra New South Wales, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Australian Oilseeds Holdings Limited, a Cayman Islands exempted company ("Australian Oilseeds" or "Pubco") and EDOC Acquisition Corp., a publicly-traded special purpose acquisition company ("EDOC") (NASDAQ:ADOC, ADOCW, ADOCR))), today announced that the Securities and Exchange Commission ("SEC")

    2/7/24 3:00:00 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADOC
    SEC Filings

    View All

    SEC Form 15-12G filed by Edoc Acquisition Corp.

    15-12G - Edoc Acquisition Corp. (0001824884) (Filer)

    4/1/24 6:02:12 AM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Edoc Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

    8-K - Edoc Acquisition Corp. (0001824884) (Filer)

    3/28/24 5:16:10 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 25-NSE filed by Edoc Acquisition Corp.

    25-NSE - Edoc Acquisition Corp. (0001824884) (Subject)

    3/22/24 8:52:21 AM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADOC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Yakira Capital Management, Inc. disposed of $2,662,742 worth of Class A Ordinary Shares (248,622 units at $10.71)

    4 - Edoc Acquisition Corp. (0001824884) (Issuer)

    2/23/23 5:01:04 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3: New insider Yakira Capital Management, Inc. claimed ownership of 275,000 units of Class A Ordinary Shares

    3 - Edoc Acquisition Corp. (0001824884) (Issuer)

    1/26/23 2:36:23 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3 filed by new insider Li Yan Michael

    3 - Edoc Acquisition Corp. (0001824884) (Issuer)

    11/7/22 5:20:00 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADOC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)

    SC 13G/A - Edoc Acquisition Corp. (0001824884) (Subject)

    2/14/24 12:48:37 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)

    SC 13G/A - Edoc Acquisition Corp. (0001824884) (Subject)

    2/13/24 4:41:59 PM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G/A filed by Edoc Acquisition Corp. (Amendment)

    SC 13G/A - Edoc Acquisition Corp. (0001824884) (Subject)

    1/31/24 6:08:55 AM ET
    $ADOC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care